Bile acids in treatment of ocular disease

Journal of Ocular Biology, Diseases, and Informatics

Volumn 2, Issue 3, 2009, Pages 149-159

  Boatright, Jeffrey H ^a   Nickerson, John M ^a   Moring, Anisha G ^a   Pardue, MacHelle T ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Bile acid; Neuroprotection; Retinal degeneration; Tauroursodeoxycholic acid; Traditional Chinese medicine; TUDCA; UDCA; Ursodeoxycholic acid

Indexed keywords

BILE ACID; NEUROPROTECTIVE AGENT; TAUROLITE; TAUROURSODEOXYCHOLIC ACID; UNCLASSIFIED DRUG; URSO FORTE; URSODEOXYCHOLIC ACID;

BEAR; CELL PROTECTION; CHINESE MEDICINE; DIARRHEA; DISEASE MODEL; DRUG MECHANISM; EYE DISEASE; GALLSTONE; HEMORRHOID; HUMAN; LIVER CIRRHOSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SORE THROAT;

EID: 76449113179     PISSN: None     EISSN: 19368445     Source Type: Journal    
DOI: 10.1007/s12177-009-9030-x     Document Type: Review

References (100)

1. Cidian Z. Dictionary of traditional Chinese medicine. Shanghai: Shanghai Science and Technology Press; 2004.
2. Lee Y-J. The use of bear bile as medicine versus tonic. In: Williamson DF and Phipps MJ, editors. Proceedings of the Third International Symposium on the Trade in Bear Parts. Seoul: TRAFFIC East Asia; 1999. p. 122-126
3. Y Feng K Siu N Wang KM Ng SW Tsao T Nagamatsu Y Tong 2009 Bear bile: dilemma of traditional medicinal use and animal protection J Ethnobiol Ethnomed 5 2 10.1186/1746-4269-5-2 19138420
4. Gabriel GG.A bitter medicine: the use of bear bile in China. In: Williamson DF and Phipps MJ, editors. Proceedings of the Third International Symposium on the Trade in Bear Parts. Seoul: TRAFFIC East Asia; 1999. p. 116-120.
5. DG Hanson 1983 Poaching: Oriental demand for undgam and paws decimates California bears Audubon 85 127 128
6. Comer C, Dixon J (2004) Illegal trade in whole black bears and black bear parts (Fisheries, S.N.P.a.V.D.o.G.a.I., eds). National Park Service, U.S. Department of the Interior
7. J Raloff 2005 A galling business Sci News 168 250 252 10.2307/4016817
8. Fund WW (2009) Wildlife Trade. http://www.cites.org/eng/app/index.shtml
9. Congress, U.S. (1973). ENDANGERED SPECIES ACT OF 1973 As Amended through the 108th Congress
10. J Mills C Servheen 1994 The Asian trade in bears and bear parts: impacts and conservation recommendations Bears: Their Biology and Management 9 161 167 10.2307/3872697
11. AF Hofmann 1999 The continuing importance of bile acids in liver and intestinal disease Arch Intern Med 159 2647 2658 10.1001/archinte.159.22.2647 1:STN:280:DC%2BD3c%2FmsVKhtw%3D%3D 10597755
12. JD Jones PE Zollman 1997 Black bear (Ursus americanus) bile composition: seasonal changes Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 118 387 390 10.1016/S0742-8413(97)00176-X 1:STN:280:DyaK1c7ivFSksw%3D%3D 9467890 (Pubitemid 28053628)
13. LR Hagey DL Crombie E Espinosa MC Carey H Igimi AF Hofmann 1993 Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores J Lipid Res 34 1911 1917 1:CAS:528:DyaK2cXlsFGk 8263415
14. S Sola DL Garshelis JD Amaral KV Noyce PL Coy CJ Steer PA Iaizzo CM Rodrigues 2006 Plasma levels of ursodeoxycholic acid in black bears, Ursus americanus: seasonal changes Comp Biochem Physiol C Toxicol Pharmacol 143 204 208 10.1016/j.cbpc.2006.02.002 16571381
15. AC MacDonald CN Williams 1985 Studies of bile lipids and bile acids of wild North American black bears in Nova Scotia, showing a high content of ursodeoxycholic acid J Surg Res 38 173 179 10.1016/0022-4804(85)90024-1 1:CAS:528:DyaL2MXhtFSns70%3D 3968875 (Pubitemid 15136761)
16. K Bentayeb R Batlle C Sanchez C Nerin C Domeno 2008 Determination of bile acids in human serum by on-line restricted access material-ultra high-performance liquid chromatography-mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 869 1 8 10.1016/j.jchromb.2008.04.045 1:CAS:528:DC%2BD1cXnt1alt7c%3D 18514045
17. T Kanazawa A Shimazaki T Sato T Hoshino 1954 Syntheses of ursodesoxycholic acid and its conjugated bile acid Proceedings of the Japanese Academy 30 391 394 1:CAS:528:DyaG2MXnsl2ntg%3D%3D
18. A Crosignani PM Battezzati KD Setchell P Invernizzi G Covini M Zuin M Podda 1996 Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study Dig Dis Sci 41 809 815 10.1007/BF02213140 1:CAS:528:DyaK28XivF2jt7k%3D 8674405 (Pubitemid 26140087)
19. WH Bachrach AF Hofmann 1982 Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. PART I Dig Dis Sci 27 737 761 10.1007/BF01393771 1:CAS:528:DyaL38XlsFGltbo%3D 7094795
20. A Ward RN Brogden RC Heel TM Speight GS Avery 1984 Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy Drugs 27 95 131 10.2165/00003495-198427020-00001 1:CAS:528:DyaL2cXhsFSntbo%3D 6365507 (Pubitemid 14223113)
21. AK Batta, et al. 1993 Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis Am J Gastroenterol 88 691 700 1:STN:280:DyaK3s3ktlelsg%3D%3D 8480734
22. H Oka, et al. 1990 A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis Gastroenterol Jpn 25 774 780 1:STN:280:DyaK3M7it1GmsA%3D%3D 1980654
23. M Parquet EH Metman A Raizman JC Rambaud N Berthaux R Infante 1985 Bioavailability, gastrointestinal transit, solubilization and faecal excretion of ursodeoxycholic acid in man Eur J Clin Invest 15 171 178 10.1111/j.1365-2362. 1985.tb00164.x 1:CAS:528:DyaL2MXltlCnsbs%3D 3930255
24. RA Rubin TE Kowalski M Khandelwal PF Malet 1994 Ursodiol for hepatobiliary disorders Ann Intern Med 121 207 218 1:STN:280: DyaK2c3ovVCjtg%3D%3D 8017748
25. A Stiehl, et al. 1990 Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis Hepatology 12 492 497 10.1002/hep.1840120308 1:STN:280:DyaK3czot1OktA%3D%3D 2401455
26. T Fedorowski G Salen A Calallilo GS Tint EH Mosbach JC Hall 1977 Metabolism of ursodeoxycholic acid in man Gastroenterology 73 1131 1137 1:STN:280:DyaE1c%2FgsVejsA%3D%3D 908492
27. AF Hofmann 1994 Pharmacology of ursodeoxycholic acid, an enterohepatic drug Scand J Gastroenterol Suppl 204 1 15 10.3109/00365529409103618 1:STN:280:DyaK2M7isFektQ%3D%3D 7824870
28. M Nakagawa C Colombo KD Setchell 1990 Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration Hepatology 12 322 334 10.1002/hep.1840120221 1:STN:280:DyaK3czmtFahsQ%3D%3D 2391071 (Pubitemid 20285797)
29. G Paumgartner U Beuers 2002 Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited Hepatology 36 525 531 10.1053/jhep.2002.36088 1:CAS:528:DC%2BD38XnvVSkt74%3D 12198643 (Pubitemid 34977162)
30. GS Tint G Salen A Colalillo D Graber D Verga J Speck S Shefer 1982 Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones Ann Intern Med 97 351 356 1:STN:280:DyaL383ot1ehtA%3D%3D 7051912
31. S Walker G Rudolph R Raedsch A Stiehl 1992 Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage Gastroenterology 102 810 815 1:STN:280:DyaK387msFSjug%3D%3D 1537519
32. KD Setchell CM Rodrigues M Podda A Crosignani 1996 Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis Gut 38 439 446 10.1136/gut.38.3.439 1:CAS:528:DyaK28XitlOjt7k%3D 8675100 (Pubitemid 26074325)
33. G Salen GS Tint S Shefer 1991 Treatment of cholesterol gallstones with litholytic bile acids Gastroenterol Clin North Am 20 171 182 1:STN:280:DyaK3M3hs1Knuw%3D%3D 2022420
34. S Saksena RK Tandon 1997 Ursodeoxycholic acid in the treatment of liver diseases Postgrad Med J 73 75 80 10.1136/pgmj.73.856.75 1:CAS:528: DyaK2sXhvVersrw%3D 9122101
35. U Leuschner M Leuschner J Sieratzki W Kurtz K Hubner 1985 Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study Dig Dis Sci 30 642 649 10.1007/BF01308413 1:STN:280:DyaL2M3ivF2jsw%3D%3D 4006646 (Pubitemid 15045039)
36. H Koga S Sakisaka M Ohishi M Sata K Tanikawa 1997 Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis Hepatology 25 1077 1084 10.1002/hep.510250505 1:STN:280:DyaK2s3os1amsQ%3D%3D 9141420
37. CM Rodrigues G Fan PY Wong BT Kren CJ Steer 1998 Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production Mol Med 4 165 178 10.1007/s0089480040165 1:CAS:528:DyaK1cXis1Wksbw%3D 9562975
38. CM Rodrigues X Ma C Linehan-Stieers G Fan BT Kren CJ Steer 1999 Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation Cell Death Differ 6 842 854 10.1038/sj.cdd.4400560 1:CAS:528:DyaK1MXnt1Crt7s%3D 10510466
39. CM Rodrigues S Sola JC Sharpe JJ Moura CJ Steer 2003 Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C release in isolated mitochondria Biochemistry 42 3070 3080 10.1021/bi026979d 1:CAS:528:DC%2BD3sXht1Oiu7s%3D 12627974 (Pubitemid 36331552)
40. F Arenas I Hervias M Uriz R Joplin J Prieto JF Medina 2008 Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells J Clin Invest 118 695 709 1:CAS:528:DC%2BD1cXhsFOms7s%3D 18188457
41. C Weitzel D Stark F Kullmann J Scholmerich A Holstege W Falk 2005 Ursodeoxycholic acid induced activation of the glucocorticoid receptor in primary rat hepatocytes Eur J Gastroenterol Hepatol 17 169 177 10.1097/00042737-200502000-00007 1:CAS:528:DC%2BD2MXntVSrtA%3D%3D 15674094 (Pubitemid 40349530)
42. Amaral JD, Viana RJ, Ramalho RM, Steer CJ, Rodrigues CM (2009). Bile acids: regulation of apoptosis by ursodeoxycholic acid. J Lipid Res 50:1721-1734
43. S Sola MM Aranha CJ Steer CM Rodrigues 2007 Game and players: mitochondrial apoptosis and the therapeutic potential of ursodeoxycholic acid Curr Issues Mol Biol 9 123 138 1:CAS:528:DC%2BD2sXltlOgsrs%3D 17489439
44. CM Rodrigues CL Stieers CD Keene X Ma BT Kren WC Low CJ Steer 2000 Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition J Neurochem 75 2368 2379 10.1046/j.1471-4159.2000. 0752368.x 1:CAS:528:DC%2BD3cXotFKnsr4%3D 11080188 (Pubitemid 30832739)
45. CD Keene CM Rodrigues T Eich C Linehan-Stieers A Abt BT Kren CJ Steer WC Low 2001 A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease Exp Neurol 171 351 360 10.1006/exnr.2001.7755 1:CAS:528:DC%2BD3MXntV2nsbc%3D 11573988 (Pubitemid 32955297)
46. SW Davies, et al. 1997 Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation Cell 90 537 548 10.1016/S0092-8674(00)80513-9 1:CAS:528:DyaK2sXlsVKrs7c%3D 9267033 (Pubitemid 27347243)
47. L Mangiarini, et al. 1996 Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice Cell 87 493 506 10.1016/S0092-8674(00)81369-0 1:CAS:528:DyaK28XmvVOrtL0%3D 8898202 (Pubitemid 26374323)
48. RJ Viana, et al. 2009 Tauroursodeoxycholic acid prevents E22Q Alzheimer's Abeta toxicity in human cerebral endothelial cells Cell Mol Life Sci 66 1094 1104 10.1007/s00018-009-8746-x 1:CAS:528:DC%2BD1MXjtFKqtr4%3D 19189048
49. RM Ramalho PM Borralho RE Castro S Sola CJ Steer CM Rodrigues 2006 Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells J Neurochem 98 1610 1618 10.1111/j.1471-4159. 2006.04007.x 1:CAS:528:DC%2BD28XhtVymtLbM 16923170 (Pubitemid 44200450)
50. RM Ramalho RJ Viana WC Low CJ Steer CM Rodrigues 2008 Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease Trends Mol Med 14 54 62 10.1016/j.molmed.2007.12.001 1:CAS:528: DC%2BD1cXitVGlt7c%3D 18218342
51. RM Ramalho RJ Viana RE Castro CJ Steer WC Low CM Rodrigues 2008 Apoptosis in transgenic mice expressing the P301L mutated form of human tau Mol Med 14 309 317 10.2119/2007-00133.Ramalho 1:CAS:528:DC%2BD1cXntV2gtLg%3D 18368144 (Pubitemid 351785704)
52. CM Rodrigues S Sola MA Brito CD Brondino D Brites JJ Moura 2001 Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate Biochem Biophys Res Commun 281 468 474 10.1006/bbrc.2001.4370 1:CAS:528:DC%2BD3MXht1aiur0%3D 11181071 (Pubitemid 32928179)
53. S Sola RE Castro PA Laires CJ Steer CM Rodrigues 2003 Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway Mol Med 9 226 234 10.2119/2003-00042.Rodrigues 1:CAS:528:DC%2BD2cXmtFygsr4%3D 15208744
54. SS Joo TJ Won DI Lee 2004 Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2) Arch Pharm Res 27 954 960 10.1007/BF02975850 1:CAS:528:DC%2BD2cXptFajtbg%3D 15473667
55. WM Duan CM Rodrigues LR Zhao CJ Steer WC Low 2002 Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease Cell Transplant 11 195 205 12075985
56. CM Rodrigues S Sola Z Nan RE Castro PS Ribeiro WC Low CJ Steer 2003 Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats Proc Natl Acad Sci U S A 100 6087 6092 10.1073/pnas.1031632100 1:CAS:528:DC%2BD3sXjvFOltb4%3D 12721362 (Pubitemid 36576935)
57. CM Rodrigues SR Spellman S Sola AW Grande C Linehan-Stieers WC Low CJ Steer 2002 Neuroprotection by a bile acid in an acute stroke model in the rat J Cereb Blood Flow Metab 22 463 471 10.1097/00004647-200204000-00010 1:CAS:528:DC%2BD38Xjt1Ogsbk%3D 11919517
58. RE Castro S Sola RM Ramalho CJ Steer CM Rodrigues 2004 The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons J Pharmacol Exp Ther 311 845 852 10.1124/jpet.104.070532 1:CAS:528:DC%2BD2cXptVKqsrs%3D 15190125 (Pubitemid 39391575)
59. IH Park MK Kim SU Kim 2008 Ursodeoxycholic acid prevents apoptosis of mouse sensory neurons induced by cisplatin by reducing P53 accumulation Biochem Biophys Res Commun 377 1025 1030 10.1016/j.bbrc.2008.06.014 1:CAS:528: DC%2BD1cXhsVGhu7%2FJ 18558085
60. A Colak B Kelten A Sagmanligil O Akdemir A Karaoglan E Sahan O Celik S Barut 2008 Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats J Clin Neurosci 15 665 671 10.1016/j.jocn.2007.06.002 1:CAS:528:DC%2BD1cXlslGit7s%3D 18343118
61. O Chazouilleres F Ballet C Legendre MT Bonnefis C Rey Y Chretien R Poupon 1991 Effect of bile acids on ischemia-reperfusion liver injury J Hepatol 13 318 322 10.1016/0168-8278(91)90075-M 1:CAS:528:DyaK38XhtVelsb4%3D 1808225
62. L Baiocchi, et al. 2008 TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKCalpha-ezrin pathway Transpl Int 21 792 800 10.1111/j.1432-2277.2008.00682.x 1:CAS:528:DC%2BD1cXhtVSgt7vM 18435680
63. AP Rolo PJ Oliveira AJ Moreno CM Palmeira 2003 Protection against post-ischemic mitochondrial injury in rat liver by silymarin or TUDC Hepatol Res 26 217 224 10.1016/S1386-6346(03)00108-6 1:CAS:528:DC%2BD3sXltF2msLs%3D 12850694 (Pubitemid 36927196)
64. S Ejiri Y Eguchi A Kishida F Ishigami Y Kurumi T Tani M Kodama 2001 Cellular distribution of thrombomodulin as an early marker for warm ischemic liver injury in porcine liver transplantation: protective effect of prostaglandin I2 analogue and tauroursodeoxycholic acid Transplantation 71 721 726 10.1097/00007890-200103270-00006 1:CAS:528:DC%2BD3MXjsleqtLY%3D 11330532
65. L Falasca, et al. 2001 Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients Transplantation 71 1268 1276 10.1097/00007890-200105150-00015 1:CAS:528:DC%2BD3MXks1Clsbw%3D 11397961
66. F Ishigami S Naka K Takeshita Y Kurumi K Hanasawa T Tani 2001 Bile salt tauroursodeoxycholic acid modulation of Bax translocation to mitochondria protects the liver from warm ischemia-reperfusion injury in the rat Transplantation 72 1803 1807 10.1097/00007890-200112150-00016 1:CAS:528:DC%2BD38XltVKjuw%3D%3D 11740392
67. M Hertl MC Hertl M Malago CE Broelsch 1999 In vivo protection of the pig liver against ischemia/reperfusion injury by tauroursodeoxycholate Langenbecks Arch Surg 384 461 466 10.1007/s004230050231 1:STN:280:DC%2BD3c%2FitVKqtA%3D%3D 10552292 (Pubitemid 29513734)
68. T Ono K Imai H Kohno M Uchida Y Takemoto DK Dhar N Nagasue 1998 Tauroursodeoxycholic acid protects cholestasis in rat reperfused livers: its roles in hepatic calcium mobilization Dig Dis Sci 43 2201 2210 10.1023/A:1026654219668 1:CAS:528:DyaK1cXntFSgurs%3D 9790455 (Pubitemid 28487248)
69. T Ono N Nagasue H Kohno M Uchida Y Takemoto DK Dhar T Nakamura 1995 Effect of tauroursodeoxycholic acid on bile flow and calcium excretion in ischemia-reperfusion injury of rat livers J Hepatol 23 582 590 10.1016/0168-8278(95)80066-2 1:CAS:528:DyaK28Xjt12m 8583148
70. G Nowak UG Noren A Wernerson HU Marschall L Moller BG Ericzon 2005 Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats Transpl Int 17 804 809 10.1111/j.1432-2277.2004.tb00514.x 1:CAS:528:DC%2BD2MXmvFSgur4%3D 15815896 (Pubitemid 41187421)
71. A Pergel K Zengin A Cercel H Aki S Kaya 2007 The effects of somatostatin and ursodeoxycholic acid in preventing the ischemic injury of the liver following Pringle maneuver in obstructive jaundice-rat model Hepatogastroenterology 54 229 233 1:CAS:528:DC%2BD2sXks1aktro%3D 17419266
72. AL Rivard CJ Steer BT Kren CM Rodrigues RE Castro RW Bianco WC Low 2007 Administration of tauroursodeoxycholic acid (TUDCA) reduces apoptosis following myocardial infarction in rat Am J Chin Med 35 279 295 10.1142/S0192415X07004813 1:CAS:528:DC%2BD2sXktVOrs7c%3D 17436368 (Pubitemid 46579083)
73. KG Rajesh R Suzuki H Maeda M Yamamoto X Yutong S Sasaguri 2005 Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway J Mol Cell Cardiol 39 766 776 10.1016/j.yjmcc.2005.07.014 1:CAS:528:DC%2BD2MXhtFCjsLbO 16171810 (Pubitemid 41464413)
74. R Guo H Ma F Gao L Zhong J Ren 2009 Metallothionein alleviates oxidative stress-induced endoplasmic reticulum stress and myocardial dysfunction J Mol Cell Cardiol 47 228 237 10.1016/j.yjmcc.2009.03.018 1:CAS:528: DC%2BD1MXnsl2itrY%3D 19344729
75. WY Lee SH Han TS Cho YH Yoo SM Lee 1999 Effect of ursodeoxycholic acid on ischemia/reperfusion injury in isolated rat heart Arch Pharm Res 22 479 484 10.1007/BF02979156 1:CAS:528:DyaK1MXnt1Gqtbo%3D 10549575
76. Arora SK., Faulkner A, Kim M, Ciavatta V, Pardue M. Tudca preserves cones in fast degenerating Rd1 mice. Invest Ophthalmol Vis Sci. 2009;50:E-Abstract 978.
77. C Bowes T Li M Danciger LC Baxter ML Applebury DB Farber 1990 Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase Nature 347 677 680 10.1038/347677a0 1:CAS:528: DyaK3MXhsFKj 1977087 (Pubitemid 20356246)
78. B Chang NL Hawes RE Hurd MT Davisson S Nusinowitz JR Heckenlively 2002 Retinal degeneration mutants in the mouse Vision Res 42 517 525 10.1016/S0042-6989(01)00146-8 1:CAS:528:DC%2BD38Xhtlektrw%3D 11853768 (Pubitemid 34169709)
79. C Gargini E Terzibasi F Mazzoni E Strettoi 2007 Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: a morphological and ERG study J Comp Neurol 500 222 238 10.1002/cne.21144 17111372 (Pubitemid 44937119)
80. B Chang, et al. 2007 Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene Vision Res 47 624 633 10.1016/j.visres.2006.11.020 1:CAS:528:DC%2BD2sXhvVGiu7w%3D 17267005 (Pubitemid 46240231)
81. JH Boatright, et al. 2006 Tool from ancient pharmacopoeia prevents vision loss Mol Vis 12 1706 1714 1:CAS:528:DC%2BD2sXnsFemsQ%3D%3D 17213800
82. MJ Phillips, et al. 2008 Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30 Invest Ophthalmol Vis Sci 49 2148 2155 10.1167/iovs.07-1012 18436848
83. Mulhern ML, Madson CJ, Thoreson W, Shinohara T. Chemical chaperones and TUDCA partially suppress degeneration of retinal photoreceptor cells in transgenic mutant rhodopsin S334ter-3 rats. Invest Ophthalmol Vis Sci. 2008;49:E-Abstract 2038.
84. RH Steinberg, et al. 1996 Transgenic rat models of inherited retinal degeneration caused by mutant opsin genes Invest Ophthalmol Vis Sci 37 S698
85. Fernandez-Sanchez L, Lax P, Esquiva G, Pinilla I, Martín-Niet J, Cuenca N. Loss of synaptic contacts in the retina is prevented by tauroursodeoxycholic acid (TUDCA) in transgenic P23H rats. Invest Ophthalmol Vis Sci. 2009;50:E-Abstract 980.
86. Fernandez-Sanchez L, Pinilla I, Campello L, Idiope M, Martin-Nieto J, Cuenca N. Tauroursodeoxycholic acid (TUDCA) slows retinal degeneration in transgenic P23H Rats. Invest Ophthalmol Vis Sci. 2008; 49:E-Abstract 2195.
87. L Chen T Dentchev R Wong P Hahn R Wen J Bennett JL Dunaief 2003 Increased expression of ceruloplasmin in the retina following photic injury Mol Vis 9 151 158 1:CAS:528:DC%2BD3sXkvVCitrc%3D 12724641
88. CE Reme C Grimm F Hafezi A Marti A Wenzel 1998 Apoptotic cell death in retinal degenerations Prog Retin Eye Res 17 443 464 10.1016/S1350-9462(98)00009- 3 1:STN:280:DyaK1cvltVyhsw%3D%3D 9777646 (Pubitemid 28432977)
89. Yang ES, Kendall C, Premji SM, Boatright JH. Tauroursodeoxycholic acid (TUDCA) prevents loss of visual function in rats. Invest Ophthalmol Vis Sci. 2008;49:E-Abstract 4933.
90. Boatright, Boyd AP, Garcia-Valenzuela E. Effect of tauroursodeoxycholic acid on mouse retinal ganglion cell degeneration following optic nerve transection. Invest Ophthalmol Vis Sci. 2005;46:E-Abstract 3180.
91. E Garcia-Valenzuela R Rayanade JC Perales CA Davidson RW Hanson SC Sharma 1997 Axon-mediated gene transfer of retinal ganglion cells in vivo J Neurobiol 32 111 122 10.1002/(SICI)1097-4695(199701)32:1<111::AID-NEU10>3.0.CO;2-N 1:CAS:528:DyaK2sXnvFentA%3D%3D 8989667 (Pubitemid 27020249)
92. ML Mulhern CJ Madson PF Kador J Randazzo T Shinohara 2007 Cellular osmolytes reduce lens epithelial cell death and alleviate cataract formation in galactosemic rats Mol Vis 13 1397 1405 1:CAS:528:DC%2BD2sXhtV2gurjK 17768385
93. Y Chen CP Liu KF Xu XD Mao YB Lu L Fang JW Yang C Liu 2008 Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advanced glycation end products in cultured mouse podocytes Am J Nephrol 28 1014 1022 10.1159/000148209 1:CAS:528:DC%2BD1cXht1Slsb3K 18648192
94. SF de Almeida G Picarote JV Fleming M Carmo-Fonseca JE Azevedo M de Sousa 2007 Chemical chaperones reduce endoplasmic reticulum stress and prevent mutant HFE aggregate formation J Biol Chem 282 27905 27912 10.1074/jbc.M702672200 17626021 (Pubitemid 47529490)
95. U Ozcan E Yilmaz L Ozcan M Furuhashi E Vaillancourt RO Smith CZ Gorgun GS Hotamisligil 2006 Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes Science 313 1137 1140 10.1126/science.1128294 16931765 (Pubitemid 44300242)
96. Q Xie VI Khaoustov CC Chung J Sohn B Krishnan DE Lewis B Yoffe 2002 Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation Hepatology 36 592 601 10.1053/jhep.2002.35441 1:CAS:528:DC%2BD38XnvVSkt7k%3D 12198651 (Pubitemid 34977169)
97. Shinohara T, Liang J, Song S, Mulhern ML, Thurston G. Chemical chaperones and bile acids protect molecular chaperones, alpha-crystallins against thermal denaturation in vitro. Invest Ophthalmol Vis Sci. 2008;49:E-Abstract 4504.
98. T Ikegami Y Matsuzaki 2008 Ursodeoxycholic acid: mechanism of action and novel clinical applications Hepatol Res 38 123 131 1:CAS:528: DC%2BD1cXptlWqtLk%3D 18034825
99. T Takatani, et al. 2004 Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome Am J Physiol Cell Physiol 287 C949 C953 10.1152/ajpcell.00042.2004 1:CAS:528:DC%2BD2cXptVyitr8%3D 15253891 (Pubitemid 39238318)
100. C Udawatte H Qian NJ Mangini BG Kennedy H Ripps 2008 Taurine suppresses the spread of cell death in electrically coupled RPE cells Mol Vis 14 1940 1950 1:CAS:528:DC%2BD1cXhsVaqu73O 18958305